Product image of Mucotex (Carbocisteine) supplied by GNH India

Mucotex

Active Ingredient:
Carbocisteine
Origin:
EU

Mucotex (Carbocisteine)

Carbocisteine, the active ingredient in Mucotex, is a mucolytic presented as an oral formulation for oral use. It helps reduce the thickness of mucus, facilitating clearance in patients with chronic bronchitis, chronic obstructive pulmonary disease, productive cough, and respiratory tract infections.

GNH India supplies Mucotex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved documentation for each batch. Clients benefit from reliable logistics, temperature‑controlled shipping where required, and responsive technical support.

Manufacturer / TM Owner

Amdeepcha Malta Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mucotex (carbocisteine) is employed in respiratory conditions where thick mucus impairs clearance.

  • Chronic bronchitis: improves mucus clearance and reduces cough frequency.
  • Chronic obstructive pulmonary disease (COPD): facilitates expectoration and eases breathing discomfort.
  • Productive cough: thins secretions to aid effective coughing.
  • Respiratory tract infections: assists in clearing infection‑related mucus.

How It Works

  • Carbocisteine acts by cleaving disulfide bonds within mucopolysaccharide chains of mucus glycoproteins. This chemical alteration reduces the viscosity and elasticity of sputum, making it less tenacious. The less viscous mucus is more readily transported by the ciliary action of the respiratory epithelium, enhancing mucociliary clearance and helping to relieve airway obstruction. By improving clearance, carbocisteine can also reduce the risk of secondary bacterial colonisation and support overall respiratory function.

Side Effects

Carbocisteine is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects

  • Nausea: mild stomach upset that may occur after oral intake.
  • Diarrhea: loose stools, usually transient.
  • Abdominal pain: discomfort in the stomach region.
  • Rash: mild skin redness or itching.

Serious or Rare Side Effects

  • Allergic reactions: swelling of face, lips, or throat requiring immediate medical attention.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Hepatic dysfunction: abnormal liver enzymes or jaundice.

Precautions & Warnings

When prescribing carbocisteine, clinicians should consider several precautionary measures to ensure safe use.

  • Renal function assessment: adjust use in patients with severe renal impairment.
  • Hepatic monitoring: observe liver function tests in individuals with known liver disease.
  • Gastro‑intestinal tolerance: monitor for persistent nausea, vomiting or diarrhea.
  • Hypersensitivity caution: discontinue if signs of allergic reaction appear.
  • Concomitant mucolytics: avoid combining with other mucolytic agents to reduce irritation risk.
  • Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Carbocisteine may interact with certain medicines, affecting either its efficacy or safety profile.

Major Interactions (Avoid)

  • Other mucolytic agents: combined use can increase gastrointestinal irritation.
  • Anticholinergic drugs: may diminish the expected improvement in mucus clearance.

Moderate Interactions (Monitor Closely)

  • Antibiotics (e.g., macrolides): monitor for altered cough response.
  • Bronchodilators: assess respiratory status as carbocisteine may enhance bronchodilator effect.
  • NSAIDs: watch for increased risk of gastrointestinal discomfort.

Frequently Asked Questions

Mucotex contains carbocisteine, a mucolytic that helps thin and loosen thick mucus in the airways. It is used to improve clearance of secretions in conditions such as chronic bronchitis, chronic obstructive pulmonary disease (COPD), productive cough, and respiratory tract infections.

Carbocisteine reduces mucus viscosity by breaking disulfide bonds in the mucopolysaccharide chains of sputum. This chemical change makes the mucus less sticky, allowing the cilia of the respiratory epithelium to transport it more efficiently toward the throat for expectoration.

The appropriate dose of Mucotex is determined by a qualified healthcare professional based on the patient’s age, weight, severity of the condition, and renal or hepatic function. Prescribers set the exact regimen according to clinical guidelines and individual needs.

Safety data for carbocisteine in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by the prescribing clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Carbocisteine differs from agents such as N‑acetylcysteine by primarily cleaving disulfide bonds in mucus glycoproteins, whereas N‑acetylcysteine also acts as an antioxidant. Clinical choice depends on the specific respiratory condition, patient tolerance, and physician preference.

Mucotex should be stored below 25 °C in its original container, protected from moisture and direct sunlight. Maintaining these conditions helps preserve the stability and potency of the oral formulation.

Mucotex is taken orally, usually with a glass of water. The tablet or liquid should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious adverse reactions, although rare, include severe allergic responses such as facial swelling, difficulty breathing, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and significant liver enzyme elevations. Immediate medical attention is required if any of these occur.

Mucotex is contraindicated in individuals with a known hypersensitivity to carbocisteine or any excipients in the formulation. Caution is also advised for patients with severe renal or hepatic impairment, and it should be avoided in combination with other mucolytic agents without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Carbocisteine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT